메뉴 건너뛰기




Volumn 53, Issue 11, 2012, Pages 2210-2213

JAK2V617F allele burden is associated with transformation to myelofibrosis

Author keywords

Ashkenazi; JAK2V617F; neoplasm; polycythemia vera; PPVMF

Indexed keywords

HYDROXYUREA;

EID: 84867155062     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.682308     Document Type: Article
Times cited : (22)

References (22)
  • 5
    • 38349101871 scopus 로고    scopus 로고
    • Classif cation and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
    • Teferi A, Vardiman JW. Classif cation and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007;22:14-22.
    • (2007) Leukemia , vol.22 , pp. 14-22
    • Teferi, A.1    Vardiman, J.W.2
  • 6
    • 84993810398 scopus 로고    scopus 로고
    • Update on JAK2 inhibitors in myeloproliferative neoplasm
    • Chan D, Koren-Michowitz M. Update on JAK2 inhibitors in myeloproliferative neoplasm. Ther Adv Hematol 2011;2:61-71.
    • (2011) Ther Adv Hematol , vol.2 , pp. 61-71
    • Chan, D.1    Koren-Michowitz, M.2
  • 7
    • 33749358349 scopus 로고    scopus 로고
    • Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
    • DOI 10.1182/blood-2006-04-018259
    • Scott LM, Scott MA, Campbell PJ, et al. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood 2006;108:2435-2437. (Pubitemid 44497530)
    • (2006) Blood , vol.108 , Issue.7 , pp. 2435-2437
    • Scott, L.M.1    Scott, M.A.2    Campbell, P.J.3    Green, A.R.4
  • 8
    • 33845755386 scopus 로고    scopus 로고
    • Polycythemia vera is not initiated by JAK2V617F mutation
    • Nussenzveig RH, Swierczek SI, Jelinek J, et al. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol 2007;35:32-38.
    • (2007) Exp Hematol , vol.35 , pp. 32-38
    • Nussenzveig, R.H.1    Swierczek, S.I.2    Jelinek, J.3
  • 9
    • 53749103194 scopus 로고    scopus 로고
    • Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens
    • Moliterno AR, Williams DM, Rogers O, et al. Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens. Exp Hematol 2008;36:1480-1486.
    • (2008) Exp Hematol , vol.36 , pp. 1480-1486
    • Moliterno, A.R.1    Williams, D.M.2    Rogers, O.3
  • 10
    • 77956439565 scopus 로고    scopus 로고
    • A prospective study of 338 patients with polycythemia vera: The impact of JAK2 (V617F) allele burden and leukocytosis on f brotic or leukemic disease transformation and vascular complications
    • Passamonti F, Rumi E, Pietra D, et al. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on f brotic or leukemic disease transformation and vascular complications. Leukemia 2010;24:1574-1579.
    • (2010) Leukemia , vol.24 , pp. 1574-1579
    • Passamonti, F.1    Rumi, E.2    Pietra, D.3
  • 11
    • 78751706637 scopus 로고    scopus 로고
    • JAK2V617F allele burden in polycythemia vera correlates with grade of myelof brosis but is not substantially af ected by therapy
    • Silver RT, Vandris K, Wang YL, et al. JAK2V617F allele burden in polycythemia vera correlates with grade of myelof brosis, but is not substantially af ected by therapy. Leuk Res 2011;35:177-182.
    • (2011) Leuk Res , vol.35 , pp. 177-182
    • Silver, R.T.1    Vandris, K.2    Wang, Y.L.3
  • 15
    • 0026649984 scopus 로고
    • High incidence of myeloproliferative disorders in Ashkenazi Jews in Northern Israel
    • Chaiter Y, Brenner B, Aghai E, et al. High incidence of myeloproliferative disorders in Ashkenazi Jews in Northern Israel. Leuk Lymphoma 1992;7:251-255.
    • (1992) Leuk Lymphoma , vol.7 , pp. 251-255
    • Chaiter, Y.1    Brenner, B.2    Aghai, E.3
  • 16
    • 0031687645 scopus 로고    scopus 로고
    • Epidemiological data in polycythaemia vera: A study of 842 cases
    • Najean Y, Rain JD, Billotey C. Epidemiological data in polycythaemia vera: a study of 842 cases. Hematol Cell Ther 1998;40:159-165. (Pubitemid 28432315)
    • (1998) Hematology and Cell Therapy , vol.40 , Issue.4 , pp. 159-165
    • Najean, Y.1    Rain, J.-D.2    Billotey, C.3
  • 17
    • 39749192828 scopus 로고    scopus 로고
    • A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)
    • DOI 10.1016/j.leukres.2007.07.003, PII S0145212607002895
    • Koren-Michowitz M, Shimoni A, Vivante A, et al. A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res 2008;32:421-427. (Pubitemid 351295916)
    • (2008) Leukemia Research , vol.32 , Issue.3 , pp. 421-427
    • Koren-Michowitz, M.1    Shimoni, A.2    Vivante, A.3    Trakhtenbrot, L.4    Rechavi, G.5    Amariglio, N.6    Loewenthal, R.7    Nagler, A.8    Cohen, Y.9
  • 18
    • 54049126083 scopus 로고    scopus 로고
    • Relapse of postpolycythemia myelof brosis after allogeneic stem cell transplantation in a polycythemic phase: Successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation
    • Benjamini O, Koren-Michowitz M, Amariglio N, et al. Relapse of postpolycythemia myelof brosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation. Leukemia 2008;22:1961-1963.
    • (2008) Leukemia , vol.22 , pp. 1961-1963
    • Benjamini, O.1    Koren-Michowitz, M.2    Amariglio, N.3
  • 19
    • 42949094077 scopus 로고    scopus 로고
    • The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea
    • DOI 10.1002/ajh.21149
    • Sirhan S, Lasho TL, Hanson CA, et al. The presence of JAK2V617F in primary myelof brosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea. Am J Hematol 2008;83:363-365. (Pubitemid 351614747)
    • (2008) American Journal of Hematology , vol.83 , Issue.5 , pp. 363-365
    • Sirhan, S.1    Lasho, T.L.2    Hanson, C.A.3    Mesa, R.A.4    Pardanani, A.5    Tefferi, A.6
  • 20
    • 68949211425 scopus 로고    scopus 로고
    • Postpolycythaemic myelof brosis: Frequency and risk factors for this complication in 116 patients
    • Alvarez-Larrán A, Bellosillo B, Martínez-Avilés L, et al. Postpolycythaemic myelof brosis: frequency and risk factors for this complication in 116 patients. Br J Haematol 2009;146:504-509.
    • (2009) Br J Haematol , vol.146 , pp. 504-509
    • Alvarez-Larrán, A.1    Bellosillo, B.2    Martínez-Avilés, L.3
  • 21
    • 76549109434 scopus 로고    scopus 로고
    • Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias
    • Abdel-Wahab O, Manshouri T, Patel J, et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res 2010;70:447-452.
    • (2010) Cancer Res , vol.70 , pp. 447-452
    • Abdel-Wahab, O.1    Manshouri, T.2    Patel, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.